These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6807803)

  • 1. Chronic renal failure: metabolic and clinical consequences.
    Kurtzman NA
    Hosp Pract (Off Ed); 1982 Aug; 17(8):107-22. PubMed ID: 6807803
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluid and electrolyte imbalances in children with chronic renal failure.
    Rodriguez-Soriano J; Arant BS; Brodehl J; Norman ME
    Am J Kidney Dis; 1986 Apr; 7(4):268-74. PubMed ID: 3962979
    [No Abstract]   [Full Text] [Related]  

  • 3. Caclium, phosphorus, and bone in renal disease and transplantation.
    Bricker NS; Slatopolsky E; Reiss E; Avioli LV
    Arch Intern Med; 1969 May; 123(5):543-53. PubMed ID: 4888973
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dialysis-free treatment of chronic kidney insufficiency].
    Armbruster KF; Ing TS; Kark RM
    Internist (Berl); 1974 Feb; 15(2):103-8. PubMed ID: 4599812
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and/or vitamin D derivatives.
    Drüeke TB; Ritz E
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):234-41. PubMed ID: 19056615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secondary hyperparathyroidism in renal insufficiency. Prevention and therapy].
    Malluche HH; Ritz E
    MMW Munch Med Wochenschr; 1976 Jan; 118(5):129-30. PubMed ID: 814442
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease.
    Slatopolsky E; Bricker NS
    Kidney Int; 1973 Aug; 4(2):141-5. PubMed ID: 4355426
    [No Abstract]   [Full Text] [Related]  

  • 8. When is Vitamin D contraindicated in dialysis patients?
    Evenepoel P
    Semin Dial; 2009; 22(3):242-4. PubMed ID: 19572999
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid correction of metabolic acidosis in chronic renal failure: effect on parathyroid hormone activity.
    Lu KC; Shieh SD; Li BL; Chu P; Jan SY; Lin YF
    Nephron; 1994; 67(4):419-24. PubMed ID: 7969674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Magnification phenomenon" in chronic renal disease.
    Bricker NS; Fine LG; Kaplan M; Epstein M; Bourgoignie JJ; Light A
    N Engl J Med; 1978 Dec; 299(23):1287-93. PubMed ID: 714096
    [No Abstract]   [Full Text] [Related]  

  • 11. Function of residual nephrons with respect to the conservative therapy of chronic renal failure.
    Schück O; Nádvorníková H; Teplan V; Malý J; Sotorník J
    Czech Med; 1985; 8(3):137-43. PubMed ID: 3932031
    [No Abstract]   [Full Text] [Related]  

  • 12. [Disorders of calcium phosphate homeostasis in patients with intermittent hemodialysis therapy].
    Pogglitsch H; Holzer H; Giessauf W; Stöckl G
    Wien Med Wochenschr; 1972 May; 122(22):311-7. PubMed ID: 5045838
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pathogenesis of hyperparathyroidism in renal failure].
    Galus K
    Pol Arch Med Wewn; 1974 Aug; 52(2):195-203. PubMed ID: 4605842
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic renal insufficiency.
    Lewy PR; Hurley JK
    Pediatr Clin North Am; 1976 Nov; 23(4):829-42. PubMed ID: 792783
    [No Abstract]   [Full Text] [Related]  

  • 15. Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients: the need for randomized trials.
    Al-Aly Z
    Kidney Int; 2007 Oct; 72(8):909-11. PubMed ID: 17914416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paricalcitol as compared with calcitriol in patients undergoing hemodialysis.
    Drüeke TB; McCarron DA
    N Engl J Med; 2003 Jul; 349(5):496-9. PubMed ID: 12890849
    [No Abstract]   [Full Text] [Related]  

  • 17. On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using "proportional reduction" of dietary phosphorus intake.
    Slatopolsky E; Caglar S; Gradowska L; Canterbury J; Reiss E; Bricker NS
    Kidney Int; 1972 Sep; 2(3):147-51. PubMed ID: 4669450
    [No Abstract]   [Full Text] [Related]  

  • 18. [Calcium metabolism in chronic uraemia and in patients on chronic intermittent haemodialysis (author's transl)].
    Skrabal F; Dittrich P
    Wien Klin Wochenschr; 1974 Apr; 86(7):169-77. PubMed ID: 4207089
    [No Abstract]   [Full Text] [Related]  

  • 19. Dysphoria induced in dialysis providers by secondary hyperparathyroidism.
    Soomro IH; Goldfarb DS
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):9-11. PubMed ID: 25516914
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of potassium secretion in chronic renal failure studied by means of amiloride.
    Yeyati NL; Prigollini D; Creparula R; Barrera E; Pertzov G; Barrera LA; Gotlieb D
    Medicina (B Aires); 1981; 41(4):431-8. PubMed ID: 7339433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.